Literature DB >> 29589964

Screening and surveillance-principles and practice.

Robert Jc Steele1.   

Abstract

Health screening can only be applied to populations, not individuals. For it to be effective, the initial screening test must be acceptable and reasonably accurate, the disease must be treatable with better outcomes when treated early and the harm and cost associated with screening must not outweigh its benefits. Robust evidence is therefore required before systematic screening is implemented. Surveillance implies the testing of people at high risk of disease and is therefore distinct from screening in both scale (smaller) and intensity (greater). In both cases, however, clear information must be provided to potential participants so that they can weigh up the balance of benefit and harm before deciding on whether or not to engage in the process.

Entities:  

Mesh:

Year:  2018        PMID: 29589964      PMCID: PMC6350463          DOI: 10.1259/bjr.20180200

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  2 in total

Review 1.  Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment.

Authors:  Federico Piñero; Melisa Dirchwolf; Mário G Pessôa
Journal:  Cells       Date:  2020-06-01       Impact factor: 6.600

Review 2.  Targeted screening in the UK: A narrow concept with broad application.

Authors:  Anna Bobrowska; Molly Murton; Farah Seedat; Cristina Visintin; Anne Mackie; Robert Steele; John Marshall
Journal:  Lancet Reg Health Eur       Date:  2022-04-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.